Sotera Health Co (NASDAQ: SHC)’s stock price has increased by 0.49 compared to its previous closing price of 12.30. However, the company has seen a 1.39% increase in its stock price over the last five trading sessions. seekingalpha.com reported 2025-05-02 that Sotera Health Company (NASDAQ:SHC ) Q1 2025 Earnings Conference Call May 1, 2025 9:00 AM ET Company Participants Michael Petras – Chairman, Chief Executive Officer Jonathan Lyons – Chief Financial Officer Jason Peterson – Vice President of Investor Relations and Treasurer Conference Call Participants Patrick Donnelly – Citi Brett Fishbin – KeyBanc Matt Sykes – Goldman Sachs Luke Sergott – Barclays Dave Windley – Jefferies Jason Bednar – Piper Sandler Michael Polark – Wolfe Research Operator Good morning. And welcome to the Sotera Health First Quarter of 2025 Earnings Call.
Is It Worth Investing in Sotera Health Co (NASDAQ: SHC) Right Now?
The price-to-earnings ratio for Sotera Health Co (NASDAQ: SHC) is 142.73x, which is above its average ratio. Moreover, the 36-month beta value for SHC is 1.87. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 2 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for SHC is 146.62M and currently, short sellers hold a 9.03% of that float. On June 10, 2025, SHC’s average trading volume was 1.25M shares.
SHC’s Market Performance
SHC’s stock has seen a 1.39% increase for the week, with a -6.58% drop in the past month and a 4.66% gain in the past quarter. The volatility ratio for the week is 1.05%, and the volatility levels for the past 30 days are at 1.67% for Sotera Health Co The simple moving average for the past 20 days is -1.25% for SHC’s stock, with a -9.08% simple moving average for the past 200 days.
Analysts’ Opinion of SHC
Many brokerage firms have already submitted their reports for SHC stocks, with Goldman repeating the rating for SHC by listing it as a “Buy.” The predicted price for SHC in the upcoming period, according to Goldman is $17 based on the research report published on May 05, 2025 of the current year 2025.
Goldman, on the other hand, stated in their research note that they expect to see SHC reach a price target of $14. The rating they have provided for SHC stocks is “Neutral” according to the report published on December 06th, 2024.
Piper Sandler gave a rating of “Neutral” to SHC, setting the target price at $13 in the report published on May 21st of the previous year.
SHC Trading at 4.72% from the 50-Day Moving Average
After a stumble in the market that brought SHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.63% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at SHC starting from WARBURG PINCUS & CO., who sale 15,000,000 shares at the price of $15.03 back on Sep 06 ’24. After this action, WARBURG PINCUS & CO. now owns 73,822,952 shares of Sotera Health Co, valued at $225,450,000 using the latest closing price.
WARBURG PINCUS & CO., the Director of Sotera Health Co, sale 15,000,000 shares at $15.03 during a trade that took place back on Sep 06 ’24, which means that WARBURG PINCUS & CO. is holding 73,822,952 shares at $225,450,000 based on the most recent closing price.
Stock Fundamentals for SHC
Current profitability levels for the company are sitting at:
- 0.28 for the present operating margin
- 0.54 for the gross margin
The net margin for Sotera Health Co stands at 0.02. The total capital return value is set at 0.11. Equity return is now at value 5.88, with 0.81 for asset returns.
Currently, EBITDA for the company is 448.23 million with net debt to EBITDA at -0.74. When we switch over and look at the enterprise to sales, we see a ratio of 2.89. The receivables turnover for the company is 8.64for trailing twelve months and the total asset turnover is 0.36. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.46.
Conclusion
To wrap up, the performance of Sotera Health Co (SHC) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
